{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:16:02Z","timestamp":1791414962020,"version":"4.3.3"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T00:00:00Z","timestamp":1413244800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0109924","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T18:04:04Z","timestamp":1413309844000},"page":"e109924","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":96,"title":["TP53 Mutational Status Is a Potential Marker for Risk Stratification in Wilms Tumour with Diffuse Anaplasia"],"prefix":"10.1371","volume":"9","author":[{"given":"Mariana","family":"Maschietto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard D.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasnim","family":"Chagtai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey D.","family":"Popov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil J.","family":"Sebire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordan","family":"Vujanic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Perlman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Grundy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Dome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Pritchard-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,10,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1200\/JCO.1998.16.12.3744","article-title":"Effect of duration of treatment on treatment outcome and cost of treatment for Wilms&apos; tumor: a report from the National Wilms&apos; Tumor Study Group","volume":"16","author":"DM Green","year":"1998","journal-title":"J Clin Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1200\/JCO.2001.19.17.3719","article-title":"Treatment with nephrectomy only for small, stage I\/favorable histology Wilms&apos; tumor: a report from the National Wilms&apos; Tumor Study Group","volume":"19","author":"DM Green","year":"2001","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/cncr.20433","article-title":"Doxorubicin for favorable histology, Stage II-III Wilms tumor: results from the National Wilms Tumor Studies","volume":"101","author":"NE Breslow","year":"2004","journal-title":"Cancer"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0140-6736(04)17139-0","article-title":"Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms&apos; tumour (SIOP 93-01 trial): a randomised controlled trial","volume":"364","author":"J de Kraker","year":"2004","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1200\/JCO.2003.01.062","article-title":"Older age is an adverse prognostic factor in stage I, favorable histology Wilms&apos; tumor treated with vincristine monochemotherapy: a study by the United Kingdom Children&apos;s Cancer Study Group, Wilm&apos;s Tumor Working Group","volume":"21","author":"K Pritchard-Jones","year":"2003","journal-title":"J Clin Oncol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1200\/JCO.2004.08.008","article-title":"The treatment of stages I-IV favorable histology Wilms&apos; tumor","volume":"22","author":"DM Green","year":"2004","journal-title":"J Clin Oncol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1016\/S1470-2045(13)70010-X","article-title":"Sustaining innovation and improvement in the treatment of childhood cancer: lessons from high-income countries","volume":"14","author":"K Pritchard-Jones","year":"2013","journal-title":"Lancet Oncol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1016\/j.ejca.2006.05.026","article-title":"Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms&apos; tumour: results of a randomised trial (UKW3) by the UK Children&apos;s Cancer Study Group","volume":"42","author":"C Mitchell","year":"2006","journal-title":"Eur J Cancer"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/00043426-200203000-00007","article-title":"Improved survival for patients with recurrent Wilms tumor: the experience at St. Jude Children&apos;s Research Hospital","volume":"24","author":"JS Dome","year":"2002","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/pbc.21267","article-title":"Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the National Wilms Tumor Study Group","volume":"50","author":"M Malogolowkin","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1002\/1097-0142(197805)41:5<1937::AID-CNCR2820410538>3.0.CO;2-U","article-title":"Histopathology and prognosis of Wilms tumors: results from the First National Wilms&apos; Tumor Study","volume":"41","author":"JB Beckwith","year":"1978","journal-title":"Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1097\/00000478-199608000-00001","article-title":"Focal versus diffuse anaplasia in Wilms tumor\u2013new definitions with prognostic significance: a report from the National Wilms Tumor Study Group","volume":"20","author":"P Faria","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1200\/JCO.2005.04.7852","article-title":"Treatment of anaplastic histology Wilms&apos; tumor: results from the fifth National Wilms&apos; Tumor Study","volume":"24","author":"JS Dome","year":"2006","journal-title":"J Clin Oncol"},{"key":"ref14","first-page":"463","article-title":"Outcome of relapses of nephroblastoma in patients registered in the SIOP\/GPOH trials and studies","volume":"20","author":"H Reinhard","year":"2008","journal-title":"Oncol Rep"},{"key":"ref15","first-page":"215","article-title":"Clonal expansion and attenuated apoptosis in Wilms&apos; tumors are associated with p53 gene mutations","volume":"55","author":"N Bardeesy","year":"1995","journal-title":"Cancer Res"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/ng0594-91","article-title":"Anaplastic Wilms&apos; tumour, a subtype displaying poor prognosis, harbours p53 gene mutations","volume":"7","author":"N Bardeesy","year":"1994","journal-title":"Nat Genet"},{"key":"ref17","first-page":"238","article-title":"Immunophenotype, mRNA expression, and gene structure of p53 in Wilms&apos; tumors","volume":"9","author":"R el Bahtimi","year":"1996","journal-title":"Mod Pathol"},{"key":"ref18","first-page":"2077","article-title":"Mutations of the p53 tumor suppressor gene occur infrequently in Wilms&apos; tumor","volume":"54","author":"D Malkin","year":"1994","journal-title":"Cancer Res"},{"key":"ref19","first-page":"483","article-title":"Mutations of p53 in Wilms&apos; tumors","volume":"8","author":"S Takeuchi","year":"1995","journal-title":"Mod Pathol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/humu.20495","article-title":"Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database","volume":"28","author":"A Petitjean","year":"2007","journal-title":"Hum Mutat"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/cncr.11325","article-title":"Clinical and biologic significance of nuclear unrest in Wilms tumor","volume":"97","author":"DA Hill","year":"2003","journal-title":"Cancer"},{"key":"ref22","first-page":"149","article-title":"Immunohistochemical detection of p53 protein expression as a prognostic factor in Wilms tumor","volume":"5","author":"F Jadali","year":"2011","journal-title":"Iran J Kidney Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.juro.2012.09.115","article-title":"p53 Immunohistochemistry Expression in Wilms Tumor: A Prognostic Tool in the Detection of Tumor Aggressiveness","volume":"189","author":"J Franken","year":"2013","journal-title":"J Urol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/gcc.20907","article-title":"Molecular profiling reveals frequent gain of MYCN and anaplasia-specific loss of 4q and 14q in Wilms tumor","volume":"50","author":"RD Williams","year":"2011","journal-title":"Genes Chromosomes Cancer"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/bib\/bbs017","article-title":"Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration","volume":"14","author":"H Thorvaldsdottir","year":"2013","journal-title":"Brief Bioinform"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"K Wang","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/biostatistics\/kxh008","article-title":"Circular binary segmentation for the analysis of array-based DNA copy number data","volume":"5","author":"AB Olshen","year":"2004","journal-title":"Biostatistics"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/bioinformatics\/btl646","article-title":"A faster circular binary segmentation algorithm for the analysis of array CGH data","volume":"23","author":"ES Venkatraman","year":"2007","journal-title":"Bioinformatics"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1093\/bioinformatics\/bti677","article-title":"A comparison study: applying segmentation to array CGH data for downstream analyses","volume":"21","author":"H Willenbrock","year":"2005","journal-title":"Bioinformatics"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2011.12.013","article-title":"Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations","volume":"148","author":"T Rausch","year":"2012","journal-title":"Cell"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ng.336","article-title":"Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma","volume":"41","author":"PA Northcott","year":"2009","journal-title":"Nat Genet"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1093\/annonc\/mds025","article-title":"Treatment and outcome of Wilms&apos; tumour patients: an analysis of all cases registered in the UKW3 trial","volume":"23","author":"K Pritchard-Jones","year":"2012","journal-title":"Ann Oncol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/pbc.24419","article-title":"Children&apos;s Oncology Group&apos;s 2013 blueprint for research: renal tumors","volume":"60","author":"JS Dome","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.ejca.2011.05.025","article-title":"The contribution of chest CT-scan at diagnosis in children with unilateral Wilms&apos; tumour. Results of the SIOP 2001 study","volume":"48","author":"AM Smets","year":"2012","journal-title":"Eur J Cancer"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/ijc.25067","article-title":"Secondary malignant neoplasms after Wilms tumor: an international collaborative study","volume":"127","author":"NE Breslow","year":"2010","journal-title":"Int J Cancer"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/pbc.23090","article-title":"Twenty-five year follow-up of childhood Wilms tumor: a report from the Childhood Cancer Survivor Study","volume":"57","author":"AM Termuhlen","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/jmg.2006.041723","article-title":"Syndromes and constitutional chromosomal abnormalities associated with Wilms tumour","volume":"43","author":"RH Scott","year":"2006","journal-title":"J Med Genet"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/humu.10081","article-title":"The IARC TP53 database: new online mutation analysis and recommendations to users","volume":"19","author":"M Olivier","year":"2002","journal-title":"Hum Mutat"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/jcb.23400","article-title":"Links between mutant p53 and genomic instability","volume":"113","author":"W Hanel","year":"2012","journal-title":"J Cell Biochem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1182\/blood-2008-04-154070","article-title":"Monoallelic TP53 inactivation is associated with poor prognosis in chronic lymphocytic leukemia: results from a detailed genetic characterization with long-term follow-up","volume":"112","author":"T Zenz","year":"2008","journal-title":"Blood"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"11547","DOI":"10.1073\/pnas.1934852100","article-title":"The presence of p53 mutations in human osteosarcomas correlates with high levels of genomic instability","volume":"100","author":"M Overholtzer","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/nrm2395","article-title":"Transcriptional control of human p53-regulated genes","volume":"9","author":"T Riley","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref43","article-title":"Effects of TP53 Mutational Status on Gene Expression Patterns Across Ten Human Cancer Types","author":"N Parikh","year":"2013","journal-title":"J Pathol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/CCO.0b013e3283414d00","article-title":"Next-generation sequencing: emerging lessons on the origins of human cancer","volume":"23","author":"GP Pfeifer","year":"2011","journal-title":"Curr Opin Oncol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/01.mph.0000149961.71266.27","article-title":"Prognostic value of quantifying apoptosis factor expression in favorable histology wilms tumors","volume":"27","author":"MA Miller","year":"2005","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref46","article-title":"Defects in the DNA mismatch repair system do not contribute to the development of childhood Wilms tumors","author":"H Segers","year":"2012","journal-title":"Pediatr Dev Pathol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/08880018.2013.780274","article-title":"Tissue expression of MLH1, PMS2, MSH2, and MSH6 proteins and prognostic value of microsatellite instability in Wilms tumor: experience of 45 cases","volume":"30","author":"G Diniz","year":"2013","journal-title":"Pediatr Hematol Oncol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0109924","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T22:10:49Z","timestamp":1588975849000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0109924"}},"subtitle":[],"editor":[{"given":"Keith William","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,10,14]]},"references-count":47,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2014,10,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0109924","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,14]]}}}